We are studying a new FDG-PET-based treatment for patients with locally advanced non-small cell lung cancer. The goal is to see if this method is safer and more effective than the standard treatment.
Health conditions and diseases that the clinical trial is designed to study and treat.
Stage III Non-Small Cell Lung Cancer (NSCLC) is a type of lung cancer that has spread to nearby lymph nodes but is not yet metastatic. This stage is characterized by larger tumors or multiple tumors that cannot be surgically removed.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.